Literature DB >> 25070729

Radioresistance of cancer stem-like cell derived from canine tumours.

A Tanabe1, T Deguchi2, T Sato2, Y Nemoto2, T Maruo2, H Madarame2, T Shida3, Y Naya4, K Ogihara4, H Sahara1.   

Abstract

Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are a small subpopulation of cancer cells that are responsible for the initiation, recurrence and metastasis of cancer. We previously demonstrated that, using the Hoechst 33342 dye-based side population technique, CSCs/CICs in canine lung adenocarcinoma cell line exist. In this study, as CSCs/CICs are known to form spheres in anchorage-independent environment in vitro, we evaluated the stemness of spheroid cells derived from canine lung adenocarcinoma and osteosarcoma cells by expression of stemness markers, and investigated radioresistance. Spheroid cells showed greater expression of stemness markers Oct-4 and CD133 gene than those of adherent-cultured cells. In nude mouse xenograft models, spheroid cells showed higher tumourigenic ability than adherent-cultured cells. In addition, spheroid cells showed significantly resistant against radioactivity as compared with adherent-cultured cells. These results suggest that spheroid cells could possess stemness and provide a CSCs/CICs research tool to investigate CSCs/CICs of canine tumour cells.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer stem-like cell; canine; lung cancer; osteosarcoma; radioresistance; radiotherapy

Mesh:

Substances:

Year:  2014        PMID: 25070729     DOI: 10.1111/vco.12110

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  7 in total

1.  Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133).

Authors:  Kristina Thamm; Sylvi Graupner; Carsten Werner; Wieland B Huttner; Denis Corbeil
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

2.  Identification of tumor-initiating cells derived from two canine rhabdomyosarcoma cell lines.

Authors:  Takuya Evan Kishimoto; Shoko Yashima; Rei Nakahira; Eri Onozawa; Daigo Azakami; Makoto Ujike; Kazuhiko Ochiai; Toshiyuki Ishiwata; Kimimasa Takahashi; Masaki Michishita
Journal:  J Vet Med Sci       Date:  2017-05-21       Impact factor: 1.267

3.  miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.

Authors:  Tao Wei; Shan Cheng; Xiao Na Fu; Lian Jie Feng
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

4.  Metabolite profiling in sphere-forming cells from canine mammary adenocarcinoma cell lines using gas chromatography-mass spectrometry.

Authors:  Masaki Michishita; Namika Saito; Satoshi Nozawa; Rina Furumoto; Takayuki Nakagawa; Touko Sato; Kazuhiko Ochiai; Daigo Azakami; Kinya Katayama; Rei Nakahira; Hiroyuki Tazaki; Yukino Machida; Toshiyuki Ishiwata
Journal:  J Vet Med Sci       Date:  2019-07-15       Impact factor: 1.267

5.  Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells.

Authors:  Katja Zscheppang; Ina Kurth; Nicole Wachtel; Anna Dubrovska; Leoni A Kunz-Schughart; Nils Cordes
Journal:  J Cancer       Date:  2016-04-02       Impact factor: 4.207

6.  CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis.

Authors:  Yang Zhao; Jing Peng; Enlong Zhang; Ning Jiang; Jiang Li; Qi Zhang; Xuening Zhang; Yuanjie Niu
Journal:  Oncotarget       Date:  2016-03-01

7.  Functional analysis of CD44 variants and xCT in canine tumours.

Authors:  Atsushi Tanabe; Kento Kimura; Hana Tazawa; Takuya Maruo; Masayuki Taguchi; Hiroeki Sahara
Journal:  Vet Med Sci       Date:  2020-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.